Drug Trial Radar · NCT05868707
OH2 Injection in Melanoma
Last checked: Nov 19, 2026Latest source record: Jul 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
340
Planned (sponsor's estimate)
Start
Mar 8, 2023
Primary completion
Mar 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- Binhui Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of OH2 injection in patients with unresectable or metastatic melanoma who have failed at least second-line standard therapy, using investigator-selected salvage chemotherapy or best supportive care (BSC) as controls.
Conditions
- Melanoma
Interventions
OH2Drug
Oncolytic Type 2 Herpes Simplex Virus
Salvage chemotherapy or best supportive careDrug
single or combined, including but not limited to dacarbazine, temozolomide, taxoid, or platinum
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival (OS)Time frame: From date of randomization until the date of death from any cause,assessed up to 3 years
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Peking University Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China · Not yet recruiting
Fujian Cancer Hosptial
Fuzhou, Fujian, China · Recruiting
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China · Not yet recruiting
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China · Not yet recruiting
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China · Not yet recruiting
Hainan Cancer Hospital
Haikou, Hainan, China · Not yet recruiting
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital
Shijiazhuang, Hebei, China · Not yet recruiting
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Not yet recruiting
The Third People's Hospital of Zhengzhou
Zhengzhou, Henan, China · Recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China · Not yet recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Not yet recruiting
Jilin Cancer Hospital
Changchun, Jilin, China · Recruiting
The first hospital of Jilin University
Changchun, Jilin, China · Not yet recruiting
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China · Not yet recruiting
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China · Not yet recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China · Not yet recruiting
The Affiliated Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China · Not yet recruiting
Weifang People's Hospital
Weifang, Shandong, China · Recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China · Recruiting
Shanxi Bethune Hospital
Taiyuan, Shanxi, China · Not yet recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
The Affiliated Cancer Hospital, Xinjiang Medical University
Ürümqi, Xinjiang, China · Not yet recruiting
Yunnan Cancer Hospital
Kunming, Yunnan, China · Not yet recruiting
Cancer Hospital Of The University Of Chinese Academy Of Sciences Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.